Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $156.53M.
ENTERPRISE VALUE (EV)
$156.53M
Nyxoah S.A.
Market Cap
$143.10M
Enterprise Value (EV)
$156.53M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Nyxoah S.A. (NYXH) | $143.10M | $156.53M |
| Protara Therapeutics, Inc. (TARA)vs › | $142.76M | $128.43M |
| Sutro Biopharma, Inc. (STRO)vs › | $141.00M | $97.45M |
| Fortress Biotech, Inc. (FBIOP)vs › | $140.52M | $8.73M |
| Immuneering Corporation (IMRX)vs › | $140.31M | $102.62M |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $146.26M | $118.39M |
| Korsana Biosciences, Inc. (KRSA)vs › | $146.76M | $145.37M |
| Alpha Cognition Inc (ACOG)vs › | $138.93M | $97.54M |
| Voyager Therapeutics, Inc. (VYGR)vs › | $147.73M | $144.53M |
| Anavex Life Sciences Corp. (AVXL)vs › | $148.27M | $29.95M |
Market Cap
$143.10M
Total Debt
$48.66M
Cash
$35.23M
Enterprise Value
$156.53M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
